首页> 美国卫生研究院文献>Elsevier Public Health Emergency Collection >1-2-(2-Benzoyl- and 2-benzylphenoxy)ethyluracils as potent anti-HIV-1 agents
【2h】

1-2-(2-Benzoyl- and 2-benzylphenoxy)ethyluracils as potent anti-HIV-1 agents

机译:1- 2-(2-苯甲酰基-和2-苄基苯氧基)乙基尿嘧啶作为有效的抗HIV-1药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-nucleoside reverse transcriptase inhibitors (NNRTI) are key components in highly active antiretroviral therapy for treating HIV-1. Herein we present the synthesis for a series of N1-alkylated uracil derivatives bearing ω-(2-benzyl- and 2-benzoylphenoxy)alkyl substituents as novel NNRTIs. These compounds displayed anti-HIV activity similar to that of nevirapine and several of them exhibited activity against the K103N/Y181C RT mutant HIV-1 strain. Further evaluation revealed that the inhibitors were active against most nevirapine-resistant mono- and di-substituted RTs with the exception of the V106A RT. Thus, the candidate compounds can be regarded as potential lead compounds against the wild-type virus and drug-resistant forms.
机译:非核苷逆转录酶抑制剂(NNRTI)是用于治疗HIV-1的高效抗逆转录病毒疗法的关键成分。在本文中,我们提出了一系列带有ω-(2-苄基和2-苯甲酰基苯氧基)烷基取代基的N1-烷基化尿嘧啶衍生物的合成,作为新型NNRTI。这些化合物显示出与奈韦拉平相似的抗HIV活性,其中一些显示出对K103N / Y181C RT突变HIV-1株的活性。进一步的评估表明,除V106A RT外,该抑制剂对大多数耐奈韦拉平的单取代和双取代的RT具有活性。因此,候选化合物可被视为对抗野生型病毒和耐药形式的潜在先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号